September 21, 2018 | London, UK
Trilogy hosted a discussion on the implications that the disclosure and transparency regulations will have on producing clinical regulatory documentation, together with our speakers:
- Robert Paarlberg (Principal at Paarlberg & Associates)
- Dr. Julia Forjanic Klapproth (Senior Partner, President at Trilogy Writing & Consulting)